Silence Therapeutics reported $62.3M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AstraZeneca USD 50.3B 2.96B Jun/2026
Autolus Therapeutics Ltd USD 74.84M 33.99M Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Novartis USD 41.95B 3.02B Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Silence Therapeutics USD 62.3M 11.76M Dec/2025